CD8A and COVID-19: Vδ2 T cells have already demonstrated prognostic importance, with immature-neutrophil-to-Vδ2 ratio shown to be a superior blood prognostic marker for predicting COVID-19 severity, when compared to the neutrophil-to-lymphocyte ratio and the neutrophil-to-CD8 T cell ratio [65].